Charlotte Center for Multiple Sclerosis

Charlotte, North Carolina

Dedicated MS Practice
5 Active TrialsInfusion CenterMedium Practice
11 MS centers statewide · Ranked #1 in North Carolina for clinical trials · #5 in North Carolina for provider count
What kind of place is this?
Research FocusedInfusion On-SitePart of Major Health System

You are in a dedicated MS center that combines specialty care, infusions, and clinical research in one setting. You can expect access to MS-focused testing, disease-modifying therapy management, and a team that includes neurologists, nurses, and a study coordinator. This is a multi-site practice, so you may be seen across different locations rather than in a single small office.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services3/5
Clinical Trials & Research4/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care4/5

About Charlotte Center for Multiple Sclerosis

This center combines dedicated MS care with an active clinical research program and multiple treatment locations across the region.

Charlotte Center for Multiple Sclerosis provides evaluation, treatment, infusion care, and MS-specific testing for people living with multiple sclerosis and related neurologic conditions. The team includes two named physicians, nurses, and a study coordinator, with care supported by affiliations with Piedmont HealthCare and Lake Norman Neurology. You can also access disease-modifying therapy management, IV steroid treatment, and a clinical research program. With care offered across three locations and infusions at five locations, the center gives patients flexible access to MS care in the Charlotte region.

Charlotte Center for Multiple Sclerosis is a dedicated MS practice in Charlotte that also cares for related conditions like neuromyelitis optica and MOG-related disease. You can get MS evaluation, treatment, infusion services, and specialized testing in one connected setting. The practice also takes part in clinical research and works across multiple regional locations.

Featured Care Team Members

Matthew (Max) Carraro, MD
Neurology, Multiple Sclerosis
Roderick I. Elias, MD
Neurology
Matthew Carraro, MD
Active MS Prescriber

Specialized Programs

clinical trials research program
MS clinics in 3 locations
infusion services at 5 locations

Partnerships & Referral Network

  • Accellacare (clinical study partnership)
  • Innovo Research (clinical study partnership)

Services & Treatments

What They Treat
multiple sclerosisrelapsing multiple sclerosissecondary progressive multiple sclerosisprimary progressive multiple sclerosisneuromyelitis opticaMOG-related diseasegeneralized myasthenia gravisParkinson's disease
How They Treat It
MS evaluationMS treatmentmultiple sclerosis clinical researchinfusion servicesappointment schedulingMS-specific testingoral and injectable disease-modifying therapy managementIV steroid treatmentsupplement recommendationsOcrevus (ocrelizumab)Tysabri (natalizumab)Briumvi (ublituximab)Rituxan (rituximab)Lemtrada (alemtuzumab)Remicade (infliximab)Solumedroloral disease-modifying therapiesinjectable disease-modifying therapiesfrexalimabcladribineteriflunomideremibrutinibozanimodofatumumabATA188
Diagnostics
EDSSMSSSSDMTTimed 25-Foot Walk9-Hole Peg TestSloan vision testingMRIlumbar puncture

Research & Clinical Trials

This center is currently involved in 5 clinical trials — ranked #1 in North Carolina for active trials

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE4
OfatumumabDisease modifying treatment (DMT)
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabFrexalimabMRI contrast-enhancing preparations

Insurance & Access

Contact
6060 Piedmont Row Dr S Suite 400, Charlotte, NC 28210
Insurance & Support

FAQs from Charlotte Center for Multiple Sclerosis

You can schedule by phone at 704-662-3077. The practice sees patients at locations in Charlotte, Huntersville, and Mooresville.

Yes. The center offers on-site infusion services and uses treatments such as Ocrevus, Tysabri, Briumvi, Rituxan, Lemtrada, and Remicade.

The center treats multiple sclerosis, including relapsing, secondary progressive, and primary progressive MS. It also cares for neuromyelitis optica, MOG-related disease, generalized myasthenia gravis, and Parkinson's disease.

Yes. The practice has a clinical trials research program and works with Accellacare and Innovo Research on clinical studies. It also lists several research therapies, including frexalimab, cladribine, teriflunomide, remibrutinib, ozanimod, ofatumumab, and ATA188.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website